The chemical class known as LOC100041106 Inhibitors represents a group of compounds specifically developed to target and inhibit the activity of the gene product of LOC100041106. This gene, identified through advanced genomic sequencing and research, is associated with a variety of cellular processes and functions. The functionality of LOC100041106 is particularly context-sensitive, meaning its role and influence can vary depending on the cellular environment and external stimuli. The inhibitors designed for LOC100041106 are characterized by their ability to selectively bind to the proteins or enzymes that are produced as a result of this gene's expression. This selective binding is critical to the inhibitors' mechanism of action, as it directly interferes with the biochemical pathways that involve the LOC100041106 gene product. By inhibiting the activity of this gene product, these compounds aim to modify the associated cellular processes, potentially impacting specific cellular functions and mechanisms.
The development of LOC100041106 Inhibitors is a complex and interdisciplinary process, requiring the integration of knowledge from molecular biology, chemistry, and pharmacology. The initial step in this development involves gaining a comprehensive understanding of the structure and function of the LOC100041106 gene product. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are utilized to gain detailed insights into the target molecule. This foundational knowledge is crucial for the rational design of inhibitors that are effective in their interaction with the target and exhibit high specificity. Typically, these inhibitors are small molecules, designed for efficient penetration into cellular membranes and to establish a stable and potent interaction with their target. The molecular design of these inhibitors is carefully optimized to ensure robust interactions with the target molecule, often involving hydrogen bonds, hydrophobic interactions, and van der Waals forces. The efficacy of these inhibitors is assessed through various biochemical assays in vitro. These assays are essential for determining the inhibitors' potency, specificity, and overall behavior under controlled experimental conditions. Such research is vital for understanding the inhibitors' mechanism of action and for further exploration into their potential impact on the intricate network of cellular pathways influenced by LOC100041106.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Binds to bacterial RNA polymerase, inhibiting transcription initiation. Not directly applicable to eukaryotic genes, but serves as a model for transcription inhibition. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Intercalates into DNA and prevents RNA synthesis by impeding the progression of RNA polymerase. Affects both prokaryotic and eukaryotic cells. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Specifically inhibits RNA polymerase II in eukaryotes, reducing mRNA synthesis and potentially lowering protein levels. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
A nucleoside analog that terminates RNA chain elongation by inhibiting RNA polymerase after incorporation into RNA. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Forms DNA crosslinks, thereby inhibiting DNA synthesis and potentially hindering gene transcription. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibitor of topoisomerase I, leading to DNA damage and possible downregulation of gene transcription. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Alkaloid that intercalates into DNA and can inhibit DNA topoisomerase II, affecting DNA replication and transcription processes. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Targets DNA topoisomerase II, leading to DNA strand breaks and potentially disrupting transcription. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Inhibits the initial elongation step of protein synthesis, potentially reducing protein levels. | ||||||